Loading...
XSHG600833
Market cap383mUSD
Jan 08, Last price  
12.59CNY
1D
-0.40%
1Q
4.66%
Jan 2017
-38.73%
Name

Shanghai No.1 Pharmacy Co Ltd

Chart & Performance

D1W1MN
XSHG:600833 chart
P/E
31.46
P/S
1.54
EPS
0.40
Div Yield, %
1.72%
Shrs. gr., 5y
-0.13%
Rev. gr., 5y
9.11%
Revenues
1.82b
-31.49%
545,502,668601,617,263602,934,141909,996,776964,530,1701,036,970,3271,147,475,7261,268,327,1221,357,670,3591,348,394,8081,414,745,4201,490,959,7551,519,029,3971,556,146,2051,176,665,7621,243,169,4881,586,903,7251,398,284,9992,655,908,5241,819,516,165
Net income
89m
-37.81%
13,133,15414,205,41312,969,53520,061,41320,014,91040,003,63730,324,41736,748,65036,434,33834,266,80037,024,83941,168,49446,034,16243,476,77147,186,33253,089,38268,540,92249,419,058143,556,29389,275,234
CFO
58m
-55.79%
2,925,46614,215,35682,998,24341,350,17120,715,40527,061,26439,915,98824,666,24456,248,1286,519,98119,198,82848,821,43336,371,167120,074,11242,793,435104,601,58184,241,40136,559,506132,310,96658,492,291
Dividend
Jun 21, 20240.125 CNY/sh
Earnings
Apr 29, 2025

Profile

Shanghai No.1 Pharmacy Co., Ltd. engages in the retail and wholesale of pharmaceutical products. The company offers products in the categories of Chinese and Western medicines, nutrition and health products, medical equipment, Chinese herbal medicines, etc. In addition, it provides consulting and guidance on safe medication, rational medication, and chronic disease medication. Shanghai No. 1 Pharmacy Co., Ltd. is based in Shanghai, China.
URL
http://www.shdyyy.com.cn/
IPO date
Feb 24, 1994
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,819,516
-31.49%
2,655,909
89.94%
Cost of revenue
1,731,129
2,351,030
Unusual Expense (Income)
NOPBT
88,387
304,878
NOPBT Margin
4.86%
11.48%
Operating Taxes
28,235
46,962
Tax Rate
31.95%
15.40%
NOPAT
60,151
257,916
Net income
89,275
-37.81%
143,556
190.49%
Dividends
(48,179)
(15,616)
Dividend yield
1.80%
0.62%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
101,054
369,819
Long-term debt
214,488
176,666
Deferred revenue
12,435
11,302
Other long-term liabilities
2,420
71
Net debt
(437,081)
(210,917)
Cash flow
Cash from operating activities
58,492
132,311
CAPEX
(13,878)
Cash from investing activities
167,141
Cash from financing activities
(331,060)
249,148
FCF
18,362
129,434
Balance
Cash
430,175
725,219
Long term investments
322,447
32,183
Excess cash
661,646
624,606
Stockholders' equity
856,799
919,468
Invested Capital
569,960
764,344
ROIC
9.02%
40.88%
ROCE
6.87%
21.12%
EV
Common stock shares outstanding
223,188
223,086
Price
12.02
6.56%
11.28
20.64%
Market cap
2,682,721
6.61%
2,516,414
20.64%
EV
2,252,647
2,312,504
EBITDA
142,395
353,198
EV/EBITDA
15.82
6.55
Interest
8,220
14,118
Interest/NOPBT
9.30%
4.63%